A study with BN 52021 demonstrates the involvement of PAF-acether in IgE-dependent anaphylactic bronchoconstriction
- 1 July 1986
- journal article
- Published by Elsevier in Prostaglandins
- Vol. 32 (1) , 121-126
- https://doi.org/10.1016/0090-6980(86)90153-x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pulmonary anti-anaphylactic activity of clenbuterol tested on actively and passively sensitized guinea-pigsEuropean Journal of Pharmacology, 1985
- Desensitization to PAF-induced bronchoconstriction and to activation of alveolar macrophages by repeated inhalations of PAF in the guinea pigBiochemical and Biophysical Research Communications, 1985
- BN 52021 and related compounds: A new series of highly specific PAF-acether receptor antagonists isolated from Ginkgo biloba L.Blood & Vessel, 1985
- The platelet‐independent release of thromboxane A2 by Paf‐acether from guinea‐pig lungs involves mechanisms distinct from those for leukotrieneBritish Journal of Pharmacology, 1984
- Pharmacologic properties of FPL 55712 administered by aerosolInflammation Research, 1984
- Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivativesEuropean Journal of Pharmacology, 1980
- Physicochemical and Functional Identity of Rabbit Platelet-Activating Factor (PAF) Released in Vivo during IgE Anaphylaxis with PAF Released in Vitro from IgE Sensitized BasophilsThe Journal of Immunology, 1979